REACH only representative: substance quantities and supply-chain coverage
The acquired REACH Article 8 permits specified non-Community manufacturers, mixture formulators and article producers to appoint an only representative by mutual agreement. The task is to define the substance and supply chain covered, relevant importer obligations and maintained quantities/customer information. A CAS match alone cannot decide the complete obligation.
Evidence retrieved 2026-10-06. Source versions and topic-specific limits are listed below.
Sourced criteria · EU
What changes the service scope?
Decision or task
What the source describes
What to prepare
Which overseas actor is appointing?
Article 8(1) specifies substance manufacture, mixture formulation or article production outside the Community and an appointed person established in the Community. [1]
Identify the actual appointing activity and legal entity rather than assuming any reseller can use this provision.
Which substances and imports are covered?
The representative fulfils the importer obligations under the specified Title and complies with other importer obligations under paragraph 2. [1]
Map substance identity/composition, mixture/article context, volume and importers before settling registration or other work.
What information stays current?
Paragraph 2 specifies practical substance background and current information on quantities, customers and supply of the latest safety-data-sheet update. [1]
Agree who supplies each update, how quantities are reconciled and how evidence is accessed.
What changes for the covered importers?
Paragraph 3 requires the non-Community manufacturer to inform importers in the same supply chain; those importers are regarded as downstream users for the purposes of REACH. [1]
Define the covered supply chain and evidence of notification; do not imply that unrelated imports are covered.
Substance identity, use, volume, exemptions and applicable registration/restriction provisions remain incomplete. Article 8 alone does not establish that a substance is registered or compliant.
A scoped evidence and handoff plan
Use this checklist to gather your business or product details before speaking with a specialist. The items below explain what to record and suggest useful supporting documents. You can add your own answers in the editable project brief.
Which overseas actor is appointing?
Identify the actual appointing activity and legal entity rather than assuming any reseller can use this provision.
Useful evidence: Actor/manufacturing description and appointment parties.
Which substances and imports are covered?
Map substance identity/composition, mixture/article context, volume and importers before settling registration or other work.
Agree who supplies each update, how quantities are reconciled and how evidence is accessed.
Useful evidence: Quantity reconciliation, customer coverage list and safety-data-sheet distribution records.
What changes for the covered importers?
Define the covered supply chain and evidence of notification; do not imply that unrelated imports are covered.
Useful evidence: Written coverage/notification records linked to actual appointing entity and imports.
Work packages and dependencies
Conditional: Actor, substance and supply-chain coverage assessment — For this work package, agree the supported criteria, evidence access, covered entities/products and unresolved facts in the table above. Additional services require their own justified scope.
Questions for providers
Which exact actor, product or processing facts support the quoted scope, and what is still unresolved?
How will the listed records reach the responsible people, and who owns each change or authority request?
Which tasks and entities are excluded from the agreement, and which additional services need a separate assessment?
Sources and data dates
Read the official document in context. The audit details identify the precise locators and preserved versions used for this page.